RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) |
1 Months Ended | |||
|---|---|---|---|---|
Mar. 26, 2026 |
Sep. 30, 2026 |
Dec. 31, 2025 |
Jul. 28, 2016 |
|
| Related party payables | $ 1,537,785 | $ 1,271,685 | ||
| Director [Member] | ||||
| Related party payables | $ 1,537,785 | $ 1,271,685 | ||
| BioCorRx Inc. [Member] | ||||
| Common stock shares issued in exchange | 2,263,371 | |||
| Ownership interest | 12.15% | |||
| BioCorRx Pharmaceuticals [Member] | ||||
| Ownership retained percent | 75.80% | |||
| Ownership interest | 24.20% |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|